Dublin/Ireland – ERS Genomics announced today that the U.S. Court of Appeals for the Federal Circuit (the “Federal Circuit”) has upheld the decision by the U.S. Patent and Trademark Office’s Patent Trial and Appeal Board (“PTAB”) to terminate the interference between certain CRISPR/Cas9 patent claims owned by the Regents of the University of California, the University […]
BGI and Children’s Hospital of Philadelphia partner to expand one of the largest genomic data generation efforts for pediatric cancers and structural birth defects PHILADELPHIA, PA – Global genomics leader BGI is collaborating with the Gabriella Miller Kids First Data Resource Center at Children’s Hospital of Philadelphia (CHOP) on a new pediatric research initiative to understand the genetic causes of […]
Cambridge, Mass. Seven Bridges, the leading biomedical data platform and analytics company, today announced the launch of the new Kids First Data Resource Portal with the Gabriella Miller Kids First Data Resource Center (DRC) at the Center for Data Driven Discovery in Biomedicine (D3b) at Children’s Hospital of Philadelphia. The Gabriella Miller Kids First Data Resource Center is a new, collaborative, pediatric research […]
Former Chief Operations Officer and Delta™ System developer Ariel Notcovich promoted to drive industry adoption of the company’s core biomolecule characterization platform SOUTH SAN FRANCISCO, Calif. – Biodesy, Inc., a next-generation biomolecule characterization company, today announced the promotion of Ariel G. Notcovich to Chief Executive Officer, and the completion of a $20 million Series C financing. […]
Providing a best-in-class solution for immuno-oncology research, from RNA extraction to comprehensive data analysis, to advance therapeutic developmentSOUTH SAN FRANCISCO, Calif. — Fluidigm Corporation (NASDAQ:FLDM) and GenomOncology today announced an expanded Immuno-Oncology Gene Expression Workflow to accelerate the development of checkpoint immunotherapies and the identification of potential predictive biomarker signatures for therapeutic response. The integrated solution for […]
Antibodies.com appoints new CEO Antibodies.com has appointed Dr Claire Button as its new Chief Executive Officer. This appointment marks a step change in growth strategy as Antibodies.com aims to become the market leader for protein research tools. Dr Button, who holds a PhD in Immunopharmacology, has spent the last decade partnering with life science ventures […]
NEWARK, Calif.–Bioengineering company ATUM announces today that it has extended its 2014 agreement with Archer Daniels Midland Company (NYSE: ADM) to apply ATUM’s proprietary bioengineering technology and gene engineering platform to ADM’s process technologies. “We are extremely excited to continue working with global leader ADM,” said Claes Gustafsson, ATUM Chief Commercial Officer. “Our proprietary bioengineering […]
ORLANDO, FLA – Hesperos, Inc. announced today the receipt of a $4 million three-year NIH Phase IIb Small Business Innovation Research (SBIR) grant from the National Institutes of Health (NIH) National Center for Advancing Translational Sciences (NCATS) to increase capacity for its novel human-on-a-chip technology, and prepare its systems for regulatory approval utilizing advanced PKPD […]
Adds former Illumina operations team to develop and commercialize gene-editing technology Boulder, Colo. – Inscripta™, a leading gene-editing technology company, today announced the strategic acquisition of Solana Biosciences, a life sciences company founded by Illumina™ (NYSE: ILMN) veterans. Through the acquisition, Inscripta and Solana have joined forces to accelerate the commercialization of Inscripta’s suite of gene-editing […]
Enzootic and NRGene assemble the first high-quality female shrimp genome to enhance all-female shrimp breeding Tel Aviv, Hong Kong & St. Louis – Enzootic, an animal biotechnology and genetics company leading the all-female shrimp revolution, and NRGene, the world’s leading provider of genomic big data analysis, have completed the sequencing and assembly of the world’s first high- […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
